As in industry leader in a field with limitless potential for growth, human health, CVS is toned to be around for the long haul. As humans face constant health threats and have tant health needs, it's no surprise that CVS health has seen consistent and steady growth. As sult, CVS has even increased shareholder dividends by 10% for 2022 (CVS Health, 2022). ple this with the increasing net incomes and repayments of long-term debts exceeding 8 on USD, CVS Health appears to be doing what it can to make itself more attractive to ntial investors as well. With its expansion through acquisition of insurance provider Aetna in 3, the building of new facilities nationwide, over 300,000 employees, and over 9,900 tions, CVS is positioned as a healthcare giant and is providing a valued service to their omers, and their financial statements reflect this fact. The future continues to look bright for S and its Stakeholders